Sexual & Reproductive Health

ImQuest: Pyrimidinedione appears to prevent HIV transmission

Published in Drug Week, June 16th, 2006

Scientists from ImQuest Pharmaceuticals, Inc., presented data at the International Conference on Antiviral Research (ICAR) indicating the pyrimidinedione HIV inhibitors licensed from Samjin Pharmaceutical Co., Ltd., were highly potent candidates for development as topical microbicides to prevent the sexual transmission of HIV to women throughout the world.

HIV infection and AIDS within women has been increasing steadily worldwide and according to the World Health Organization, women accounted for 46% of adults living with HIV at the end of 2005.

Female-controlled chemical and physical barrier methods, including topical microbicides, to reduce HIV...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2006-06-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry